| Literature DB >> 26684451 |
Bart C Jongbloets1, Koen L I van Gassen1, Anne A Kan1, Anneke H O Olde Engberink1, Marina de Wit1, Inge G Wolterink-Donselaar1, Marian J A Groot Koerkamp2, Onno van Nieuwenhuizen3, Frank C P Holstege2, Pierre N E de Graan1.
Abstract
Febrile seizures are the most prevalent type of seizures among children up to 5 years of age (2-4% of Western-European children). Complex febrile seizures are associated with an increased risk to develop temporal lobe epilepsy. To investigate short- and long-term effects of experimental febrile seizures (eFS), we induced eFS in highly febrile convulsion-susceptible C57BL/6J mice at post-natal day 10 by exposure to hyperthermia (HT) and compared them to normotherm-exposed (NT) mice. We detected structural re-organization in the hippocampus 14 days after eFS. To identify molecular candidates, which entrain this structural re-organization, we investigated temporal changes in mRNA expression profiles eFS 1 hour to 56 days after eFS. We identified 931 regulated genes and profiled several candidates using in situ hybridization and histology at 3 and 14 days after eFS. This is the first study to report genome-wide transcriptome analysis after eFS in mice. We identify temporal regulation of multiple processes, such as stress-, immune- and inflammatory responses, glia activation, glutamate-glutamine cycle and myelination. Identification of the short- and long-term changes after eFS is important to elucidate the mechanisms contributing to epileptogenesis.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26684451 PMCID: PMC4684321 DOI: 10.1371/journal.pone.0145247
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Hyperthermia induces upregulation of neurofilament protein-expression.
(A) Neurofilament (NF) immunostaining in the hippocampus of a normothermic (NT) control animal, 14 days post-hyperthermia exposure. Square marks subfield enlargement; panel B. (B) Immunostaining for NF in the stratum lucidum of NT control animal (left panel) and in hyperthermia-exposed (HT) littermate (right panel). (C) Comparison of NF-based DAB staining in the stratum lucidum between NT and HT littermates. All HT (n = 10) animals showed increased DAB-staining in the stratum lucidum. Pair-wise comparison of DAB-staining intensities showed increased NF expression in HT animals compared to NT littermates (n = 10), Wilcoxon signed-rank test, * indicates a significance of P = 0.0049. Tukey-style box plots. Scalebars: 100 μm.
Top 30 differentially expressed genes (up- and down- regulated) 1 hour after eFS.
| 1 hour post-eFS | ||||
|---|---|---|---|---|
|
| ||||
|
|
|
|
|
|
| ENSMUSG00000028195 |
| cysteine rich protein 61 | 8.04 | 0.0000 |
| ENSMUSG00000031558 |
| slit homolog 2 (Drosophila) | 5.68 | 0.0000 |
| ENSMUSG00000052684 |
| Jun oncogene | 3.13 | 0.0000 |
| ENSMUSG00000021250 |
| FBJ osteosarcoma oncogene | 3.04 | 0.0000 |
| ENSMUSG00000023034 |
| nuclear receptor subfamily 4, group A, member 1 | 2.99 | 0.0000 |
| ENSMUSG00000038418 |
| early growth response 1 | 2.62 | 0.0000 |
| ENSMUSG00000029657 |
| heat shock 105kDa/110kDa protein 1 | 2.46 | 0.0000 |
| ENSMUSG00000004951 |
| heat shock protein 1 | 2.40 | 0.0000 |
| ENSMUSG00000024190 |
| dual specificity phosphatase 1 | 2.34 | 0.0000 |
| ENSMUSG00000005483 |
| DnaJ (Hsp40) homolog, subfamily B, member 1 | 2.25 | 0.0000 |
| ENSMUSG00000026628 |
| activating transcription factor 3 | 2.11 | 0.0000 |
| ENSMUSG00000019997 |
| connective tissue growth factor | 2.08 | 0.0000 |
| ENSMUSG00000022602 |
| activity regulated cytoskeletal-associated protein | 1.97 | 0.0000 |
| ENSMUSG00000006057 |
| ATP synthase, H+ transporting, mitochondrial F0 complex, subunit c1 (subunit 9) | 1.90 | 0.0000 |
| ENSMUSG00000053877 |
| Snf2-related CREBBP activator protein | 1.90 | 0.0000 |
| ENSMUSG00000028214 |
| GTP binding protein (gene overexpressed in skeletal muscle) | 1.89 | 0.0000 |
| ENSMUSG00000028907 |
| UTP11-like, U3 small nucleolar ribonucleoprotein, (yeast) | 1.86 | 0.0000 |
| ENSMUSG00000020205 |
| pleckstrin homology-like domain, family A, member 1 | 1.75 | 0.0000 |
| ENSMUSG00000020818 |
| major facilitator superfamily domain containing 11 | 1.75 | 0.0000 |
| ENSMUSG00000021810 |
| ecdysoneless homolog (Drosophila) | 1.68 | 0.0000 |
| ENSMUSG00000037266 |
| DNA segment, Chr 4, Wayne State University 53, expressed | 1.65 | 0.0000 |
| ENSMUSG00000020423 |
| B cell translocation gene 2, anti-proliferative | 1.64 | 0.0000 |
| ENSMUSG00000030847 |
| BCL2-associated athanogene 3 | 1.63 | 0.0000 |
| ENSMUSG00000078698 |
| MAS-related GPR, member A3 | 1.63 | 0.0000 |
| ENSMUSG00000021453 |
| growth arrest and DNA-damage-inducible 45 gamma | 1.62 | 0.0000 |
| ENSMUSG00000031765 |
| metallothionein 1 | 1.61 | 0.0000 |
| ENSMUSG00000021367 |
| endothelin 1 | 1.59 | 0.0000 |
| ENSMUSG00000073676 |
| heat shock protein 1 (chaperonin 10) | 1.56 | 0.0000 |
| ENSMUSG00000032531 |
| angiomotin-like 2 | 1.55 | 0.0000 |
| ENSMUSG00000048222 |
| microfibrillar-associated protein 1B | 1.54 | 0.0000 |
|
| ||||
|
|
|
|
|
|
| ENSMUSG00000020863 |
| LUC7-like 3 (S. cerevisiae) | 0.62 | 0.0000 |
| ENSMUSG00000015090 |
| prostaglandin D2 synthase (brain) | 0.64 | 0.0000 |
| ENSMUSG00000041378 |
| claudin 5 | 0.68 | 0.0000 |
| ENSMUSG00000071337 |
| cytotoxic granule-associated RNA binding protein 1 | 0.71 | 0.0000 |
| ENSMUSG00000030495 |
| solute carrier family 7 (cationic amino acid transporter, y+ system), member 10 | 0.71 | 0.0000 |
| ENSMUSG00000029570 |
| LFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase | 0.74 | 0.0000 |
| ENSMUSG00000046470 |
| SRY-box containing gene 18 | 0.74 | 0.0000 |
| ENSMUSG00000028645 |
| solute carrier family 2 (facilitated glucose transporter), member 1 | 0.74 | 0.0000 |
| ENSMUSG00000000253 |
| guanosine monophosphate reductase | 0.77 | 0.0000 |
| ENSMUSG00000030218 |
| matrix Gla protein | 0.78 | 0.0047 |
| ENSMUSG00000026822 |
| lipocalin 2 | 0.78 | 0.0009 |
| ENSMUSG00000030711 |
| sulfotransferase family 1A, phenol-preferring, member 1 | 0.79 | 0.0000 |
| ENSMUSG00000040055 |
| gap junction protein, beta 6 | 0.80 | 0.0000 |
| ENSMUSG00000048001 |
| hairy and enhancer of split 5 (Drosophila) | 0.81 | 0.0000 |
| ENSMUSG00000046546 |
| family with sequence similarity 43, member A | 0.81 | 0.0000 |
| ENSMUSG00000032422 |
| sorting nexin 14 | 0.81 | 0.0000 |
| ENSMUSG00000029231 |
| platelet derived growth factor receptor, alpha polypeptide | 0.81 | 0.0000 |
| ENSMUSG00000050505 |
| protocadherin 20 | 0.81 | 0.0000 |
| ENSMUSG00000022508 |
| B cell leukemia/lymphoma 6 | 0.82 | 0.0000 |
| ENSMUSG00000030707 |
| coronin, actin binding protein 1A | 0.82 | 0.0000 |
| ENSMUSG00000041073 |
| NAC alpha domain containing | 0.82 | 0.0000 |
| ENSMUSG00000016921 |
| serine/arginine-rich splicing factor 6 | 0.82 | 0.0000 |
| ENSMUSG00000038175 |
| myosin regulatory light chain interacting protein | 0.82 | 0.0000 |
| ENSMUSG00000017760 |
| cathepsin A | 0.82 | 0.0000 |
| ENSMUSG00000001240 |
| receptor (calcitonin) activity modifying protein 2 | 0.82 | 0.0000 |
| ENSMUSG00000043131 |
| MOB kinase activator 1A | 0.82 | 0.0000 |
| ENSMUSG00000070167 |
| Small nucleolar RNA SNORA57 | 0.83 | 0.0000 |
| ENSMUSG00000075602 |
| lymphocyte antigen 6 complex, locus A | 0.83 | 0.0000 |
| ENSMUSG00000028655 |
| major facilitator superfamily domain containing 2A | 0.83 | 0.0000 |
| ENSMUSG00000050295 |
| forkhead box C1 | 0.84 | 0.0000 |
Fc: Fold change represents expression values of HT animals divided by expression values of NT animals. P-value BH-corrected: Benjamini and Hochberg (BH) error corrected p-values.
Differentially expressed genes (up- and down- regulated) three, fourteen, and fifty-six days post-eFS.
|
| ||||
|
| ||||
|
|
|
|
|
|
| ENSMUSG00000001911 |
| nuclear factor I/X | 1.32 | 0.0414 |
| ENSMUSG00000003410 |
| ELAV (embryonic lethal, abnormal vision, Drosophila)-like 3 (Hu antigen C) | 1.20 | 0.0319 |
| ENSMUSG00000066551 |
| high mobility group box 1 | 1.16 | 0.0050 |
| ENSMUSG00000071337 |
| cytotoxic granule-associated RNA binding protein 1 | 1.16 | 0.0195 |
| ENSMUSG00000024501 |
| dihydropyrimidinase-like 3 | 1.16 | 0.0181 |
| ENSMUSG00000024268 |
| CUGBP, Elav-like family member 4 | 1.14 | 0.0414 |
| ENSMUSG00000001020 |
| S100 calcium binding protein A4 | 1.14 | 0.0317 |
| ENSMUSG00000028399 |
| protein tyrosine phosphatase, receptor type, D | 1.14 | 0.0115 |
| ENSMUSG00000024109 |
| neurexin I | 1.13 | 0.0319 |
| ENSMUSG00000038900 |
| ribosomal protein L12 | 1.12 | 0.0022 |
| ENSMUSG00000053128 |
| ring finger protein 26 | 1.12 | 0.0252 |
| ENSMUSG00000027962 |
| vascular cell adhesion molecule 1 | 1.12 | 0.0319 |
| ENSMUSG00000024799 |
| transmembrane 7 superfamily member 2 | 1.11 | 0.0181 |
| ENSMUSG00000003198 |
| zinc finger protein 959 | 1.11 | 0.0312 |
| ENSMUSG00000059325 |
| HOP homeobox | 1.11 | 0.0181 |
| ENSMUSG00000032047 |
| acetyl-Coenzyme A acetyltransferase 1 | 1.11 | 0.0119 |
| ENSMUSG00000022194 |
| poly(A) binding protein, nuclear 1 | 1.11 | 0.0424 |
| ENSMUSG00000060675 |
| phospholipase A2, group XVI | 1.11 | 0.0331 |
| ENSMUSG00000031451 |
| growth arrest specific 6 | 1.11 | 0.0414 |
| ENSMUSG00000049932 |
| H2A histone family, member X | 1.11 | 0.0119 |
| ENSMUSG00000024411 |
| aquaporin 4 | 1.11 | 0.0119 |
| ENSMUSG00000030605 |
| milk fat globule-EGF factor 8 protein | 1.10 | 0.0195 |
|
| ||||
|
|
|
|
|
|
| ENSMUSG00000052305 |
| hemoglobin, beta adult major chain | 0.75 | 0.0002 |
| ENSMUSG00000069919 |
| hemoglobin alpha, adult chain 1 | 0.80 | 0.0103 |
| ENSMUSG00000069917 |
| hemoglobin alpha, adult chain 2 | 0.83 | 0.0195 |
| ENSMUSG00000027375 |
| myelin and lymphocyte protein, T cell differentiation protein | 0.85 | 0.0012 |
| ENSMUSG00000032517 |
| myelin-associated oligodendrocytic basic protein | 0.86 | 0.0016 |
| ENSMUSG00000006205 |
| HtrA serine peptidase 1 | 0.88 | 0.0103 |
| ENSMUSG00000040055 |
| gap junction protein, beta 6 | 0.88 | 0.0195 |
| ENSMUSG00000006782 |
| 2',3'-cyclic nucleotide 3' phosphodiesterase | 0.89 | 0.0103 |
| ENSMUSG00000049892 |
| RAS, dexamethasone-induced 1 | 0.90 | 0.0119 |
| ENSMUSG00000062591 |
| tubulin, beta 4A class IVA | 0.90 | 0.0461 |
| ENSMUSG00000070282 |
| RIKEN cDNA 3000002C10 gene | 0.90 | 0.0195 |
| ENSMUSG00000054459 |
| visinin-like 1 | 0.90 | 0.0423 |
| ENSMUSG00000022594 |
| Ly6/neurotoxin 1 | 0.90 | 0.0195 |
| ENSMUSG00000036634 |
| myelin-associated glycoprotein | 0.90 | 0.0319 |
| ENSMUSG00000079018 |
| lymphocyte antigen 6 complex, locus C1 | 0.91 | 0.0312 |
| ENSMUSG00000090071 |
| cyclin-dependent kinase 5, regulatory subunit 2 (p39) | 0.91 | 0.0181 |
| ENSMUSG00000017009 |
| syndecan 4 | 0.91 | 0.0369 |
| ENSMUSG00000028843 |
| SH3 domain binding glutamic acid-rich protein-like 3 | 0.92 | 0.0119 |
|
| ||||
|
| ||||
|
|
|
|
|
|
| ENSMUSG00000018501 |
| nuclear receptor co-repressor 1 | 1.27 | 0.0494 |
| ENSMUSG00000006782 |
| 2',3'-cyclic nucleotide 3' phosphodiesterase | 1.26 | 0.0295 |
| ENSMUSG00000037625 |
| claudin 11 | 1.25 | 0.0078 |
| ENSMUSG00000028385 |
| sorting nexin family member 30 | 1.21 | 0.0112 |
| ENSMUSG00000063077 |
| kinesin family member 1B | 1.18 | 0.0475 |
| ENSMUSG00000025038 |
| EF-hand domain (C-terminal) containing 2 | 1.17 | 0.0335 |
| ENSMUSG00000029684 |
| Wiskott-Aldrich syndrome-like (human) | 1.15 | 0.0112 |
| ENSMUSG00000054459 |
| visinin-like 1 | 1.15 | 0.0494 |
| ENSMUSG00000036526 |
| caspase recruitment domain family, member 11 | 1.15 | 0.0123 |
| ENSMUSG00000036985 |
| zinc finger, DHHC domain containing 9 | 1.15 | 0.0475 |
| ENSMUSG00000076439 |
| myelin oligodendrocyte glycoprotein | 1.13 | 0.0494 |
|
| ||||
|
|
|
|
|
|
| ENSMUSG00000023087 |
| CCR4 carbon catabolite repression 4-like (S. cerevisiae) | 0.86 | 0.0295 |
| ENSMUSG00000030218 |
| matrix Gla protein | 0.86 | 0.0037 |
|
| ||||
|
| ||||
|
|
|
|
|
|
| ENSMUSG00000024617 |
| calcium/calmodulin-dependent protein kinase II alpha | 0.89 | 0.0120 |
Fc: Fold change represents expression values of HT animals divided by expression values of NT animals. P-value BH-corrected: Benjamini and Hochberg (BH) error corrected p-values.
Fig 2Hierarchical clustering analysis of mRNA expression after eFS.
Hierarchical clustering analysis of differentially expressed genes (930) in all experimental littermate couples (1 hour, 3 and 14 days post-eFS). Rows depict differential expression levels per HT/NT littermate couple, per time-point after eFS. Clustering was performed based on gene and sample clustering using Pearson correlation on average linkage. Tree cluster, right from heat-map, shows hierarchical distance between samples from the different time points. Differential gene expression (log2(Fc) between HT/NT littermate couples is shown in the heatmap as upregulated (red), downregulated (green), or no change (white) according to colored-scale bar.
Fig 3Validation of microarray results by qPCR analysis.
Gene expression levels as determined by qPCR (Rn) in normothermic (NT) and hyperthermic (HT) animals compared to fold-change in expression of 5 genes as detected by microarray analysis (Rm). P < 0.05 was considered significant (one-tailed Student’s t-test). Indicated are mean ± standard error of the mean.
Fig 4Gene ontology (GO) enrichment analysis on differentially expressed genes after hyperthermia exposure.
GO biological process classifications with a P < 0.05 are depicted (up- and downregulation) per time point. Numbers between brackets represent total Panther GO annotated genes used for GO analysis per geneset. P-value per GO classification is shown (black bar, -log2(P value)), with corresponding fold enrichment (grey bar). Bold denoted GO classifications show significant enrichment (P < 0.05) after Benjamini and Hochberg (BH) error correction.
Fig 5Expression of candidate genes mRNA related to structural reorganization.
(A, C, E, G) Representative images of Nrxn1, Dpysl3, Ptprd, and Slit2 gene expression in the hippocampus of NT (left panel) and HT (right panel) animals three days after eFS. (B, D, F, H) Comparison of Nrxn1, Dpysl3, Ptprd, and Slit2 gene expression levels in subfields of the hippocampus in HT (n = 9, red bars) animals compared to NT (n = 9, blue bars) littermates. Ptprd is upregulated in the CA2 subfield of the hippocampus of HT animals, * indicates a significant difference of P = 0.0097, littermate-paired Student’s t-test. Bars represents mean ± standard error of the mean. Scalebars in panel A, C, E, and G: 500μm.
Fig 6Hyperthermia induced upregulation of 2',3'-cyclic nucleotide 3' phosphodiesterase (CNP) in the stratum lucidum.
(A) Normal expression of CNP in the hippocampus of a normothermic (NT) control animal 14 days post-hyperthermia exposure. Square marks subfield enlargement, panel B and C. (B) Expression of CNP in the stratum lucidum of NT control animal (left panel) and hyperthermia-exposed (HT) littermate (right panel). Arrows indicates CNP-positive staining in the stratum lucidum. (C) Comparison of CNP-based DAB staining in the stratum lucidum between NT and HT littermates. All HT animals showed increased DAB-staining in the stratum lucidum. Increased expression of CNP were observed in HT animals compared to NT littermates, Wilcoxon signed-rank test, * indicates P = 0.0078. Tukey-style box plots. Scalebars: 100μm.
Fig 7Timed regulation of biological processes after eFS.
Bar blackness indicates the peak effect of the process. P10: postnatal day 10, 1H: 1 hour post-eFS, 3D: 3 days post-eFS, 14D: 14 days post-eFS, 56D: 56 days post-eFS, Glu/Gln cycle: glutamate/glutamine cycle.